A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight

Completed · Phase 2 · NCT06230523

Conditions: Obesity, Overweight

Research payments reported, 2025: $2.4M
U.S. investigators named: 47
Sites paid: 49
Planned or actual enrollment: 263

About the trial

Sponsor: Eli Lilly and Company
Tested: Eloralintide (drug), Placebo (drug)
Dates: Started 2024-02-05; completion 2025-08-14
Results posted: Yes

The main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to investigate weight management efficacy and safety with LY3841136 compared with placebo in adult participants with obesity or overweight. The study will last about 64 weeks and may include up to 17 visits.

From ClinicalTrials.gov, last updated 2026-06-24. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Eli Lilly and Company reported $2.4M in research payments for this study in 2025 (92 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

Monroe Biomedical Research $213,728
Institute for Liver Health LLC $182,827
Charter Research LLC $176,002
Headlands Horizons LLC $163,274
Sociedad Espanola De Medicina De La Adolescencia $142,118
Great Lakes Clinical Trials $135,324
Cti Holdings Inc DBA Community Research Management Associates Inc $118,205
Rochester Clinical Research Inc $112,645
Peninsula Headlands LLC $84,567
Suncoast Clinical Research $78,313
Las Vegas Medical Research LLC $75,813
Studymetrix Research LLC $74,795
Endocrine Ips PLLC $66,868
Arcturus Healthcare PLC, Troy Internal $54,959
Louisville Metabolic $48,457
Tekton Research Inc $48,052
Pacific Diabetes and Endocrine Center $46,899
Velocity Clinical Research Inc $43,937
Medication Management LLC $43,711
Cotton Oneil Msd of Stormont Vail Healthcare $43,245
Dent Neurosciences Research Center Inc $41,446
Central Washington Health Services $41,103
Lucida Clinical Trials $39,557
Tribe Clinical Research LLC $39,141
Danville Orthopedic Clinic Inc $31,129
Lucas Research Inc $29,842
Future Search Trials of Dallas LP $29,310
Norcal Medical Research Inc $26,550
Ascension Medical Group $22,957
Medical Research PArtners $20,299
Erg Holding Co LLC DBA St Louis Clinical Trials LLC $20,299
Ima Evaluations LLC DBA Ima Clinical Research $12,178
Iowa Diabetes and Endocrinology Rsrch Cntr $11,721
Northshore University Healthsystem - Evanston Hospital, IL $10,958
Seen Medical of Ma PC DBA Knownwell $8,091
University at Buffalo $5,995
Palos Verdes Medical Group $3,084
Dallas Diabetes and Endo Research Center PA $2,080
Lightship Inc $1,990
Knownwell $1,634
Futuresearch Trials of Neurology LP $1,327
Northeast Research Institute $1,320
Medex Healthcare Research Inc $1,182
Endeavor Clinical Trials PA $1,033
Yshay Shlesinger MD $1,026
Wenatchee Valley Hospital $749
Andrew J Lewin Med DBA National Rsrch Institute $525
North Suffolk Neurology $505
Cleveland Clinic, OH $232
$5

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.

At a glance

About the trial

Industry funding

U.S. investigators named on this study

Sites paid to run it